Correlation of the retinal histology with the optic coherence tomography
Keywords:
optic coherence tomography, cystic macular edema, serum neuroepitelial detachment, secondary health care.Abstract
A descriptive and cross-sectional study of 53 patients, assisted in the Ophthalmology Service of "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital in Santiago de Cuba, was carried out from January to December, 2011, aimed at describing the correlation between the retinal tissular structure of those affected and the image obtained by the optic coherence tomograph. The obtained information was processed by means of the SPSS statistical program version 11.5. The patients older than 70 years; hypertension and diabetes mellitus prevailed as personal pathological history and there were not significant differences between both sexes. The most frequent found tomographic patterns were serum neuroepitelial detachment and cystic macular edema. The comparison and evaluation of the hiporreflectivity and hiperreflectivity lines of the tomograph and the different layers of the retinal tissular architecture evidenced the possibility to correlate both of them and achieve a more comprehensive understanding of the macular damage.
Downloads
References
http://www.ecured.cu/Retina
2. Ţălu SD. Optical coherence tomography in the diagnosis and monitoring of retinal diseases. 2013; 18(3):130-6.
3. Pinilla I, Ruiz Moreno JM, Cuenca N. Correlación de la tomografía de coherencia óptica con la histología retiniana. Arch Soc Esp Oftalmol. 2012 [citado 12 Mar 2013];87(9). Disponible en: http://scielo.isciii.es/scielo.php?pid=S0365-66912012000900001&script=sci_arttext
4. Lang GE, Berta A, Eldem BM, Simader C, Sharp D, Holz FG. Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the restore extension study. Ophthalmology. 2013; 120(10): 2004-12.
5. Virgili G, Menchini F, Murro V, Peluso E, Rosa F, Casazza G. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015 [citado 12 Mar 2013]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438571/
6. Burgess PI, MacCormick IJ, Harding SP, Bastawrous A, Beare NA, Garner P, et al. Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review. Diabet Med. 2013; 30(4):399-412.
7. Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res. 2012; 47(4):171-88.
8. Retinopatía hipertensiva. Wikipedia. 2013 [citado 15 May 2013]. Disponible en: https://es.wikipedia.org/wiki/Retinopat%C3%ADa_hipertensiva
9. Stephan FE. Exercise therapy in type 2 diabetes. Acta Diabetol. 2009; 46:263-78.
10. KarlbergCh, FalkCh, Green A, KatrinSjølie A, Grauslund J. Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol. 2012; 49(4): 263-8.
11. Tatsuya Y, Keiichi M, Shuichiro Y, Tsuyoshi K, Nobuo I, Atsushi H, et al. Recurrent macular edema due to branch retinal vein occlusion after intravitreal injection of Bevacizumab. J Ophthalmol. 2013; 6: 415-974.
12. Pareja Ríos A, Serrano García MA, Marrero Saavedra MD, Abraldes López VM, Reyes Rodríguez MA, Cabrera López F, et al. Guías de práctica clínica de la SERV: Manejo de las complicaciones oculares de la diabetes. Retinopatía diabética y edema macular. Arch Soc Esp Oftalmol. 2009 [citado 15 May 2013]; 84 (9). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912009000900003
13. Verona Ugando L, Rodríguez Valdivia M, Leiva González Y. Morbilidad en la consulta de retina en el Servicio de Oftalmología de Ciego de Ávila. MEDICIEGO. 2011 [citado 19 Jun 2013]; 17(1). Disponible en: http://bvs.sld.cu/revistas/mciego/Vol17_01_%202011/articulos/t-3.html
14. Sociedad Panamericana de Retina y Vítreo. Consenso latinoamericano sobre la degeneración macular relacionada con la edad. 2012.
15. Gregori Gisbert I, Aguirre Balsalobre F, García Sánchez J, León Salvatierra G, Mengual Verdú E, Hueso Abancéns JR. Coriorretinopatía serosa central recidivante y crónica. Estudio del espesor retiniano al mes del tratamiento con una inyección de bevacizumab intravítreo. Arch Soc Esp Oftalmol. 2011 [citado 12 Mar 2013]; 86 (12). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912011001200004&lng=es&nrm=iso&tlng=es
16. Gallego Pinazo R, Marín Lambíes C, Marín Olmos F, Martínez R, Fons R, Díaz Llopis ML. Dexametasona intravítrea como potenciador del tratamiento anti-VEGF en la degeneración macular asociada a la edad neovascular: recuperando un viejo aliado. Arch Soc Esp Oftalmol. 2010 [citado 12 Mar 2013]; 85 (2). Disponible en: http://scielo.isciii.es/scielo.php?pid=S0365-66912010000200006&script=sci_arttext
17. Guerra García RA, Rodríguez Rodríguez BN, Eguía Martínez F, Rodríguez Rodríguez VR, Díaz Arencibia O. Microperimetría y tomografía de coherencia óptica en operados por cirugía convencional del desprendimiento de retina. Rev Cubana Oftalmol. 2008 [citado 12 Mar 2013]; 21 (2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21762008000200007
18. Lima Gómez V. Comparación del grosor macular con y sin edema en pacientes diabéticos mexicanos. Rev Mex Oftalmol. 2007; 81(4):214-8.
19. Ling Y, Chi-Chin S, Wan-Chen K, Lan-Hsin Ch, Chih-Hung C, Bi-Yu H, et al. Hemoglobina glicosilada y volumen macular en pacientes con diabetes. Análisis de la correlación entre el nivel de hemoglobina glicosilada y el volumen macular en pacientes con diabetes, sin edema macular diabético. Acta Ophthalmol. 2010; 88:753–8.
20. Solé González J, Abreu González R, Alonso Plasencia M, Abreu Reyes P. Espesor y volumen macular normal en tomografía de coherencia óptica de dominio espectral. Arch Soc Canar Oftal. 2012; 23:19-25.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
